Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > GUD can take over
View:
Post by Kensin1953 on Apr 11, 2017 3:39pm

GUD can take over

GUD is within 7% of its 52 weekk high.  MSL is 50% down, Noblish Helath Corp (NHC) down 70%  MSL down From $2.20 to $1.10 at 50%   Of Course VRX down from $48.76 to $12.77 currently a 74% drop in the last 52 weeks.
Are there any other winners in this space other than GUD?

JMO
Comment by Spidey2332 on Apr 11, 2017 5:20pm
I too am sorry to lose Peter, bad move on my eyes but maybe time will prove me wrong. The Gag order that seems to be in place can only mean good things.(deal of some kind) If they were in financial trouble they would not incur further debt to have someone else see the same numbers. I may be wrong but I think the company is being evaluated for a fair purchase price. In these cases it is common ...more  
Comment by peter75 on Apr 11, 2017 6:35pm
Hey spidey if Msl set up a room for potential buyers to go over the paper than Msl should announce it  The cfo called me back a few weeks ago and he told me they had undertaken the action of selling yet they never mentioned a thing in their confrence call strike one Strike two ,the debt covenence is too agressive and he stated he is in talks to re work the payment schedules  He called ...more  
Comment by Spidey2332 on Apr 12, 2017 5:12am
Peter. Something just doesn't smell right. They would announce if they were courting buyers but if a deal is in the works they would be tight lipped as it seems they are from what Kensin says. No insider selling, a strong balance sheet still, and the massive volume when they went into review still leaves me optimistic or just plain stupid. I am sure we won't have to wait too much longer to ...more  
Comment by jammo71 on Apr 12, 2017 8:09am
They did announce that:
Comment by peter75 on Apr 12, 2017 10:18am
Spidey what do they have to sell that isn't mortgaged to the nines i wanted them as a growth story i lost faith when the cfo told me they began talks of selling with Rothschild in December yet no mention in the c call that is disgusting Thet do not have a lot of cash when you factor out the repayment time lines better places to be than here
Comment by Spidey2332 on Apr 12, 2017 10:53am
I hear you Peter and you are right on many fronts. My situation is a bit different than yours as I only need 1.35 to break even and I think I will see at least that so I will wait. We all have to manage our own and I am happy overall that you still came out ahead. Happy trails my friend.
Comment by peter75 on Apr 11, 2017 6:45pm
Kensin crh is up sixty percent since January I think its a buy and could see  20 plus over 18 month
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities